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Background-—Percutaneous coronary intervention (PCI) is sometimes performed with the intent to lower cardiovascular risk before
high-risk noncardiac surgery (HRNCS). There are limited data on the frequency and outcome of PCIs performed in this setting.
Methods and Results-—We assessed the frequency, characteristics, and in-hospital outcomes of patients undergoing PCI as part
of the preoperative workup for HRNCS among all 61 145 elective PCIs performed between 2002 and 2009 at 14 hospitals in the
Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Propensity matching was performed to compare outcomes of
patients undergoing PCI before HRNCS with all other elective PCI patients. The frequency of PCI before HRNCS was low (4.2%).
Patients undergoing PCI before HRNCS were older (67.3 versus 64.9 years, P<0.0001) and had a greater burden of comorbidity.
Patients undergoing PCI before HRNCS had an increase in unadjusted major adverse cardiovascular events, postprocedure
transfusion, contrast-induced nephropathy, nephropathy requiring dialysis, and same-admission coronary artery bypass graft
surgery, but there was no difference in mortality (0.27% versus 0.14%, P=0.11). However, in propensity score–matched samples,
there was a significant difference only in nephropathy requiring dialysis.
Conclusions-—The incidence of PCI performed in preparation for high-risk noncardiac surgery is low, and these procedures are
currently being performed on a highly selected high-risk patient population. ( J Am Heart Assoc. 2014;3:e000388 doi: 10.1161/
JAHA.113.000388)
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C oronary artery disease is a source of major complica-tions after surgery, and the role of preoperative coronary
revascularization to reduce the risk of adverse cardiovascular
events before high-risk noncardiac surgery (HRNCS) remains
controversial. Since the early part of the past decade, several
important studies have shown that prophylactic coronary
revascularization and optimal medical management produce
similar outcomes after major noncardiac surgery.1–4
Accordingly, the American College of Cardiology/American
Heart Association guidelines on perioperative cardiovascular
evaluation and care for noncardiac surgery state that “the role
of prophylactic perioperative percutaneous coronary interven-
tion in reducing untoward perioperative complications
appears limited to patients with unstable active coronary
artery disease who would be appropriate candidates for
emergent or urgent revascularization.”5 The 2011 American
College of Cardiology Foundation/American Heart Associa-
tion/Society for Cardiovascular Angiography and Interven-
tions guidelines echo this by issuing a Class III
recommendation: “Routine prophylactic coronary revascular-
ization should not be performed in patients with stable
coronary artery disease before noncardiac surgery.”6
Given the recommendations of these guidelines and the
publication of these studies suggesting a lack of benefit for
prophylactic percutaneous coronary interventions (PCIs)
before HRNCS, one would expect the number of PCIs
performed as part of the preparation for HRNCS to be few
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and to be performed only on highly selected patients who are
at high risk for postoperative cardiovascular complications.
However, it is unclear how commonly PCI is performed in
preparation for HRNCS in contemporary practice. Further-
more, the characteristics of patients undergoing PCI before
HRNCS and how they might differ from the larger population
of patients receiving PCI are unknown. Using data from the
Blue Cross Blue Shield of Michigan Cardiovascular Consor-
tium (BMC2) registry, we assessed for trends in and outcome
of PCIs performed before HRNCS.
Methods
Our study cohort was composed of 61 145 consecutive
elective PCIs performed at the 14 hospitals in Michigan that
participated in the BMC2 registry continuously between
January 2002 and December 2009.
Standardized data collection forms were used by trained
personnel to collect demographic, procedural, and outcomes
information. Medical records of all patients who underwent
coronary artery bypass graft surgery (CABG) or who died
during their hospital stay were reviewed to ensure accuracy.
An additional 2% of cases were randomly selected for audit.
All data collection processes were prospectively defined, and
the collection of data was approved by the University of
Michigan’s Institutional Review Board, as well as the local
review board from each participating center. Further details
have been previously published.7–10
The study population for this analysis included only
patients who were classified as undergoing elective PCI. PCIs
were classified as elective if the patients on whom the PCI
was performed met all of the following conditions: they had
not had a myocardial infarction (MI) within the previous
7 days; were not in shock; had not had a cardiac arrest during
or immediately before the current admission; were not
receiving intravenous heparin, nitroglycerin, glycoprotein IIb-
IIIa inhibitor, or vasopressors before the procedure; and did
not have an intra-aortic balloon pump before the start of the
procedure. Patients were classified as undergoing PCI before
HRNCS if the operator performing the PCI deemed HRNCS to
be the primary indication for the PCI procedure. Of note, there
were 332 patients for whom the HRNCS status was not
defined; these patients were included in the elective PCI
cohort but were excluded from comparisons between pre-
HRNCS PCIs and non-HRNCS PCIs. Clinical outcomes
evaluated included in-hospital death, vascular complications,
in-hospital MI, transfusion rates, gastrointestinal bleed,
nephropathy requiring dialysis, contrast-induced nephropathy
(defined as a rise in the serum creatinine level of 0.5 mg/dL),
stroke or transient ischemic attack, emergency CABG, any
CABG, and overall major adverse cardiovascular events,
defined as any in-hospital stroke or transient ischemic attack,
MI, CABG, revascularization, or death.
Statistical Analysis
Continuous variables are expressed as meanSD, and discrete
variables are expressed as frequency counts and percentages.
Differences in discrete variables between groups were evalu-
ated by the v2 test and, when needed, Fisher’s exact test.
Continuous variables were analyzed using the t test and
Wilcoxon rank sum test. Trends over time were analyzed using
the Cochran-Armitage test. Because of multiple baseline
differences in the population of patients who were undergoing
PCI before HRNCS, propensity matching was used before
comparing between-group outcomes. The probability or pro-
pensity score of being a pre-HRNCS patient if all other variables
were known was calculated using a nonparsimonious logistic
regression model. The variables included in the propensity
model were patient age, patient body mass index, renal
function and dialysis status, World Health Organization defined
anemia (<13 g/dL for men and <12 g/dL for women), current
tobacco use, presence of extra-cardiac vascular disease,
hypertension, diabetes, chronic obstructive pulmonary dis-
ease, congestive heart failure, significant valve disease, atrial
fibrillation, history of cardiac arrest, recent gastrointestinal
bleeding, previous PCI, previous CABG, and previous MI.
Greedy matching was then used to match pre-HRNCS
patients with elective non-HRNCS patients with similar
characteristics. In-hospital outcomes for the PCI-related
hospitalizations were then compared within the propensity-
matched cohort. SAS Version 9.2 software (SAS Institute)
was used for analysis.
Results
There were 61 145 elective PCIs performed at the 14
hospitals in the BMC2 registry that participated between
January 2002 and December 2009. Of these, 2592 (4.23% of
patients with HRNCS status defined) PCIs were performed as
part of the preoperative preparation for HRNCS. The incidence
of preoperative PCIs significantly declined during the study
period (Figure 1). The majority of this decline was from 2002
to 2003. In a post-hoc analysis, we reexamined the trend from
2003 to 2009 and found that the decline was not significant if
2002 data were excluded.
There was significant variability in the proportion of pre-
HRNCS PCIs performed at the participating hospitals (Fig-
ure 2); this variability was not correlated with the total
number of PCIs performed at each hospital.
The baseline clinical characteristics of the patient popula-
tions are shown in Table 1. The pre-HRNCS population was
older, and the patients were more likely to be female and to
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be white. The pre-HRNCS population also had a higher burden
of comorbidity; there were higher rates of current tobacco
use, hypertension, diabetes, extracardiac vascular disease,
valve disease, renal failure, gastrointestinal bleeding, and
chronic obstructive pulmonary disease. In addition, the pre-
HRNCS patients had higher baseline creatinine and lower
baseline hemoglobin levels. The nonpreoperative, elective PCI
population had a higher incidence of prior MI, prior PCI, and
prior CABG. PCIs performed in preparation for HRNCS
required more contrast and more fluoroscopy time. The
patients undergoing PCI in preparation for HRNCS had fewer
restenotic lesions, although the lesions were more likely to be
calcified. They were significantly more likely to have PCI for
more than one vessel and significantly more likely to receive
bare metal rather than drug-eluting stents. There were no
significant differences in the ejection fraction or number of
patients with 3-vessel disease.
The post-PCI outcomes of interventions performed on
patients before HRNCS compared with all elective non-
HRNCS patients are shown in Table 2. In an unadjusted
analysis, patients undergoing PCI in preparation for HRNCS
had a higher risk of major adverse cardiovascular events,
postprocedure transfusion, contrast-induced nephropathy,
in-hospital nephropathy requiring dialysis, and need for
Figure 1. PCIs done in preparation for high-risk noncardiac
surgery (HRNCS) as a percentage of total elective PCIs in the
BMC2 cohort, 2002–2009. BMC2 indicates Blue Cross Blue Shield
of Michigan Cardiovascular Consortium; PCI, percutaneous coro-
nary intervention.
Figure 2. Hospital variation in pre-HRNCS PCIs as a percentage of total elective PCIs. BMC2 indicates
Blue Cross Blue Shield of Michigan Cardiovascular Consortium; HRNCS, high-risk noncardiac surgery; PCI,
percutaneous coronary intervention.
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CABG. There were no significant differences with regard to
in-hospital mortality, vascular complications, stroke and
transient ischemic attack, MI, gastrointestinal bleeding, or
need for emergency CABG. However, when outcomes were
adjusted via propensity matching, patients undergoing PCI
before HRNCS had higher rates only for the event of
nephropathy requiring dialysis (Table 3). In a supplementary
analysis with patients exact-matched within institutions
(total number of matched patients 1875), results were
similar (data not shown).
Discussion
In this study, we analyzed the incidence, characteristics, and
outcomes of patients with stable coronary artery disease
Table 1. Characteristics of All Elective PCIs With Defined HRNCS Status in the BMC2 Cohort, 2002–2009
Pre-HRNCS PCI (n=2570) Nonpreoperative PCI (n=58 243) P Value
Age, y, SD 67.3 (10.8) 64.9 (11.3) <0.0001
Female, % 39.0 33.2 <0.0001
White, % 77.0 79.4 0.004
African American, % 6.9 8.1 0.03
Current tobacco use, % 21.8 19.4 0.002
History of hypertension, % 86.4 84.6 0.01
Diabetes mellitus, % 42.0 35.6 <0.0001
History of atrial fibrillation, % 7.5 7.3 0.64
Prior myocardial infarction, % 29.9 36.5 <0.0001
History of congestive heart failure, % 12.2 12.5 0.64
Extracardiac vascular disease, % 43.2 24.6 <0.0001
Significant valve disease, % 5.9 3.9 <0.0001
History of cardiac arrest, % 0.7 1.0 0.1
History of percutaneous coronary intervention, % 33.4 51.2 <0.0001
History of coronary artery bypass graft surgery, % 18.3 21.2 0.0004
Chronic obstructive pulmonary disease, % 19.1 15.4 <0.0001
History of gastrointestinal bleeding, % 1.4 0.9 0.006
Baseline creatinine, mg/dL, SD 1.62 (1.9) 1.15 (0.9) <0.0001
Renal failure and dialysis, % 8.3 1.3 <0.0001
Baseline hemoglobin, g/dL, SD 13.4 (1.8) 13.7 (1.7) <0.0001
Ejection fraction, SD 54.5 (10.9) 54.2 (10.6) 0.16
Total contrast, mL, SD 218 (99) 209 (91) <0.0001
Total fluoroscopy time, min, SD 16.1 (12.8) 15.1 (11.9) <0.0001
Left main stenosis >70% 3.0 3.7 0.05
Restenotic lesion, % 6.0 9.2 <0.0001
Thrombus, % 2.5 3.1 0.01
Calcification, % 24.4 20.3 <0.0001
3-Vessel disease, % 19.1 19.0 0.88
2 Lesions, % 23.5 22.9 0.48
≥3 Lesions, % 6.0 5.9 0.83
PCI for 1 vessel, % 86.3 88.0 0.01
PCI for 2 vessels, % 12.8 11.3 0.02
PCI for ≥3 vessels, % 0.8 0.7 0.62
BMC2 indicates Blue Cross Blue Shield of Michigan Cardiovascular Consortium; HRNCS, high-risk noncardiac surgery; PCI, percutaneous coronary intervention.
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undergoing PCI as part of the preoperative preparation for
HRNCS. We found that the incidence of PCIs performed in
preparation for HRNCS was relatively low and declined during
the study period. Furthermore, PCI before HRNCS is per-
formed mainly on a select group of patients with a large
burden of perioperative comorbidity.
Our data suggest that only a small percentage of highly
selected patients are undergoing PCI as part of the preoper-
ative preparation for HRNCS. The patients in the pre-HRNCS
PCI population were older and had higher rates of hyperten-
sion, diabetes, prior stroke, extracardiac vascular disease,
valve disease, gastrointestinal bleeding, chronic obstructive
pulmonary disease, and renal failure than did the elective,
non-HRNCS PCI population. These comorbidities are likely to
be associated with a high risk of perioperative complications.
Similarly, these factors mean that the patients who undergo
PCI in preparation for HRNCS are at a higher risk for
complications from the PCI itself. In an unadjusted analysis,
we found that preoperative PCI led to higher rates of major
adverse cardiovascular events, postprocedure MI, postproce-
dure transfusion, and in-hospital nephropathy requiring dial-
ysis. However, when a propensity-adjusted analysis was
performed, the only difference found was a higher rate of
nephropathy requiring dialysis in patients undergoing PCI in
preparation for HRNCS. This may be related to the higher
volume of contrast used in these patients and their greater
degree of comorbidity. It is also possible that this was simply
a chance finding, as no adjustment for multiple comparisons
was made.
The small number of patients combined with the high-risk
characteristics suggests that physicians are highly selective in
performing PCI with the intent of reducing operative risk.
However, it is not clear if the high risk of complications with
PCI seen in this population negates any expected reduction in
perioperative complications. This question merits assessment
in a randomized controlled trial.
Our data show a decline in the proportion of PCIs during
the study period, although the largest decline occurred during
the first 2 years of the study. The reasons for this sharp
decline versus the smaller degree of decline during the
remainder of the study period remain unclear; of note, there
were no differences in the data collection practices or
definitions during this time.
We observed a considerable variation between hospitals in
the proportion of PCIs performed as part of the preparation
for HRNCS (1.71% to 10.48%). There was no correlation
between the total number of PCIs performed at a hospital and
the proportion of PCIs performed in preparation for HRNCS. It
is possible that this difference may relate to differences in the
type and number of surgical procedures being performed at
these institutions; some of the institutions with a high
proportion of PCI before HRNCS have a busy organ transplant
program or are referral centers for patients with advanced
aortic disease, and the practice of regularly performing pre-
HRNCS PCI in these patients may explain part of the variation.
Data on the specific surgery that followed PCI are not
collected, and we were thus unable to explore this possibility.
It is also possible that these differences may reflect practice
variation at these institutions, and further research is
warranted to explore this hypothesis.
It is also interesting to note that there were several
landmark trials published during the study period. The CARP
Table 2. Unadjusted Outcomes in Patients Undergoing PCI Before HRNCS Compared With Non-HRNCS Elective Patients
PCI Before HRNCS (n=2570), % Nonpreoperative PCI (n=58 243), % P Value
Emergency CABG 0.39 0.21 0.06
All CABG 0.89 0.48 0.004
Contrast nephropathy* 2.87 1.73 0.001
Nephropathy requiring dialysis 0.34 0.03 <0.0001
Postprocedure transfusion 2.98 1.88 <0.0001
Stroke/TIA 0.12 0.15 >0.999
Myocardial infarction 1.95 1.50 0.07
Vascular complication 1.71 1.47 0.32
Gastrointestinal bleeding 0.31 0.39 0.53
Death 0.27 0.14 0.10
MACE 3.35 2.31 0.0007
PCI indicates percutaneous coronary intervention; HRNCS, high-risk noncardiac surgery; CABG, coronary artery bypass graft surgery; TIA, transient ischemic attack; MACE, major adverse
cardiovascular events.
*Patients with history of renal failure requiring dialysis are excluded.
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(Coronary Artery Revascularization Prophylaxis) trial, with
results published in December 2004, showed that preop-
erative PCI did not improve outcomes in 510 patients
randomized to revascularization or medical therapy before
major vascular surgery; the DECREASE-V (fifth Dutch
Echocardiographic Cardiac Risk Evaluation Applying Stress
Echocardiography) Pilot Study, with results published in
May 2007, showed that preoperative PCI did not improve
outcomes in 101 high-risk patients randomized to revascu-
larization or medical therapy before major vascular sur-
gery.3,4 We did not see a decline in the number of pre-
HRNCS PCIs performed in our cohort in association with
publication of these study results. It is possible that
practitioners were already being selective in choosing
patients for preoperative PCI and that further declines
were not possible. It is also possible that the publication of
these studies, and the subsequent publication in September
2007 of the American College of Cardiology/American
Heart Association guidelines on perioperative cardiovascular
evaluation and care for noncardiac surgery, did not produce
a significant impact on practice to be discerned within the
study period.5
Study Limitations
This study has several limitations. First, we analyzed data
from 14 hospitals in one state, and, accordingly, our results
may not be generalizable to other settings. However, these
hospitals represent a wide range of practice patterns, from
small hospitals to quaternary referral centers. Second, our
data are observational and were entered into a quality
improvement registry; even though the data were abstracted
by trained professionals and randomly audited for accuracy,
the results may be susceptible to ascertainment bias. Third,
our data relied on the physician performing the PCI included in
the registry to decide whether the PCI was being performed
in preparation for HRNCS. Fourth, our data are limited to
in-hospital outcomes, and we are not able to assess the
outcomes of the patients after the index hospitalization or the
specific types of HRNCS or the outcomes of the surgery for
which patients underwent preparatory PCI. Finally, we do not
have data on the total number and type of surgical procedures
that are performed at these institutions. However, it is likely
that these patients make up a very small proportion of the
total number of patients undergoing noncardiac procedures at
these hospitals.
Conclusion
The incidence of PCI performed in preparation for HRNCS is
low. These procedures are currently being performed on a
highly selected high-risk patient population.
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Table 3. Propensity-Matched Outcomes in Patients Undergoing PCI Before HRNCS Compared With Non-HRNCS Elective Patients
PCI Before HRNCS (n=2358), % Nonpreoperative PCI (n=2358), % P Value
Emergency CABG 0.38 0.34 0.81
All CABG 0.81 0.81 >0.999
Contrast nephropathy* 2.87 2.61 0.66
Nephropathy requiring dialysis 0.32 0.05 0.04
Postprocedure transfusion 2.88 3.10 0.67
Stroke/TIA 0.13 0.17 >0.999
Myocardial infarction 2.04 1.61 0.28
Vascular complication 1.65 1.99 0.38
Gastrointestinal bleeding 0.30 0.34 0.80
Death 0.25 0.47 0.22
MACE 3.31 2.80 0.31
PCI indicates percutaneous coronary intervention; HRNCS, high-risk noncardiac surgery; CABG, coronary artery bypass graft surgery; TIA, transient ischemic attack; MACE, major adverse
cardiovascular events.
*Patients with history of renal failure requiring dialysis are excluded.
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